High CXCR3 on Leukemic Cells Distinguishes
Aged
Aged, 80 and over
Biomarkers
CD5 Antigens
/ metabolism
Cell Adhesion Molecules
/ metabolism
Cell Movement
Chemotaxis
/ immunology
Female
Humans
Immunoglobulin Heavy Chains
/ genetics
Immunoglobulin Variable Region
/ genetics
Immunophenotyping
Kaplan-Meier Estimate
Leukemia, Lymphocytic, Chronic, B-Cell
/ diagnosis
Male
Middle Aged
Mutation
Prognosis
ROC Curve
Receptors, CXCR3
/ genetics
Receptors, Chemokine
/ metabolism
Journal
Journal of immunology research
ISSN: 2314-7156
Titre abrégé: J Immunol Res
Pays: Egypt
ID NLM: 101627166
Informations de publication
Date de publication:
2020
2020
Historique:
received:
20
04
2020
accepted:
21
05
2020
entrez:
18
8
2020
pubmed:
18
8
2020
medline:
12
6
2021
Statut:
epublish
Résumé
Despite the shared pattern of surface antigens, neoplastic cells in chronic lymphocytic leukemia (CLL) are highly heterogeneous in CD5 expression, a marker linked to a proliferative pool of neoplastic cells. To further characterize CD5
Identifiants
pubmed: 32802894
doi: 10.1155/2020/7084268
pmc: PMC7322588
doi:
Substances chimiques
Biomarkers
0
CD5 Antigens
0
CXCR3 protein, human
0
Cell Adhesion Molecules
0
Immunoglobulin Heavy Chains
0
Immunoglobulin Variable Region
0
Receptors, CXCR3
0
Receptors, Chemokine
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
7084268Informations de copyright
Copyright © 2020 Gayane Manukyan et al.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Curr Cancer Drug Targets. 2016;16(8):669-688
pubmed: 27055580
Leukemia. 2018 Sep;32(9):2028-2031
pubmed: 30030508
Haematologica. 2016 Mar;101(3):e99-102
pubmed: 26589908
Blood. 2006 Feb 1;107(3):859-61
pubmed: 16223776
Blood. 2013 Feb 28;121(9):1501-9
pubmed: 23264597
Exp Hematol. 2017 Feb;46:31-37.e10
pubmed: 27693386
Mol Med. 2011;17(11-12):1374-82
pubmed: 21968788
Osteoarthritis Cartilage. 2018 Sep;26(9):1247-1256
pubmed: 29753948
Br J Pharmacol. 2013 Apr;168(7):1662-74
pubmed: 23170857
Blood. 2009 Nov 26;114(23):4832-42
pubmed: 19789386
Blood. 1999 Sep 15;94(6):1848-54
pubmed: 10477713
Blood. 2005 Nov 15;106(10):3575-83
pubmed: 16076869
Haematologica. 2007 Mar;92(3):349-56
pubmed: 17339184
Leuk Res. 2019 Apr;79:60-68
pubmed: 30852300
Blood. 2002 Dec 15;100(13):4537-43
pubmed: 12393419
Blood. 2011 Jan 13;117(2):563-74
pubmed: 20940416
Cell Rep. 2013 Aug 15;4(3):566-77
pubmed: 23933259
J Immunol Res. 2019 Jul 16;2019:3575803
pubmed: 31396542
Leukemia. 2018 Feb;32(2):332-342
pubmed: 28584254
Leuk Res. 2011 Jun;35(6):750-6
pubmed: 21093051
J Clin Invest. 2005 Mar;115(3):755-64
pubmed: 15711642
Blood. 2008 Jun 15;111(12):5446-56
pubmed: 18216293
Blood. 2016 Sep 22;128(12):1609-13
pubmed: 27480113
Blood. 2007 Nov 1;110(9):3352-9
pubmed: 17684154
Semin Cancer Biol. 2010 Dec;20(6):424-30
pubmed: 20883788
J Exp Med. 2000 Mar 6;191(5):883-90
pubmed: 10704468
Nat Genet. 2016 Mar;48(3):253-64
pubmed: 26780610
Leuk Res. 2018 Sep;72:113-119
pubmed: 30149317
Blood. 2016 Jul 28;128(4):563-73
pubmed: 27252234
J Exp Med. 2001 Dec 3;194(11):1639-47
pubmed: 11733578